Exparel bupivacaine regulatory update

FDA posted a notice on its Adverse Event Reporting System (AERS) that

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE